E Qure Corporation (CE) (EQUR) Quote

EQUR: SEC registration revoked:

https://www.sec.gov/files/litigation/opinions/2023/34-98688.pdf

EQUR SEC Admin. Proceeding for severely delinquent Financials:

https://www.sec.gov/litigation/admin/2023/34-97564.pdf

Will check it out asap.

Thanks.

“Our management believes that our operations will generate revenues in the US beginning of 2022. We expect that FDA approval for our BST Device will improve our ability to generate revenues from sales in other geographic areas.”

- from latest filing on 1/13/2022

That would be for their BST Device correct?

Any sources for real world data as to how effective it actually is?

Always looking for new and innovative med/biotech coming from microcaps.

"Minimal" capital invested with astronomical rewards if they hit the target.

TIA

Got this one on my top 2 watch list

“Our management believes that our operations will generate revenues in the US beginning of 2022. We expect that FDA approval for our BST Device will improve our ability to generate revenues from sales in other geographic areas.”

Source: 10-Q

There isn’t much recent info out there. Only the filings...

Where can I find more info on this stock?
Can be a winner but must read first

Well someone decided to throw $1,600 on this...

That’s a start!

:)

Waiting for FDA approval

EQUR SECURITY DETAILS

Share Structure

Market Cap Market Cap
5,527,399
04/15/2020

Authorized Shares
500,000,000
04/15/2020

Outstanding Shares
34,546,243
04/15/2020

Restricted
21,065,321
04/15/2020

Unrestricted
13,480,922
04/15/2020

Held at DTC
4,934,921
04/15/2020

TAKE NOTICE HERE FOLKS!

Float
13,480,922
05/15/2019

....anyone else here or am I all alone in this one?

;)

Are we on the Breakout Boards yet?
LOL

Looks like someone was loading at open... approx $20,000 worth up to 0.17...

I can't find any post anywhere. $ volume is big today. hope it comes

We got some volume... can it turn into something???

EQUR heading to 0.2+ bounce from this nice 8k today

Item 8.01 Other Events.



E-Qure Corp., a Delaware corporation (the “Company”), reported today that it has successfully completed its 2018 funding program in the total amount of $1.231 Million (the “2018 Funding Program”). The 2018 Funding Program included three stages, which included: (1) the successfully closing of its Subscription Rights Offering pursuant to a registration statement on Form S-1 (the “Registration Statement”); (2) the completion of the Company’s private Unit Offering pursuant to Regulation S (the “Reg S Unit Offering”; and (3) the conversion of debt to equity by its management team, all as discussed more fully below.



In June 2018, the Company received net proceeds of $532,147 from the Subscription Rights Offering pursuant to the Registration Statement that was declared effective under the Securities Act of 1933, as amended (the “Act”) by the SEC on May 10, 2018.



Following the second quarter ended June 30, 2018, the Company, pursuant to its Reg S Unit Offering, raised an additional $423,400 from the private sale of a total of 4,234,000 Units at $0.10 per Unit, each consisting of: (i) one share of Common Stock; (ii) one Class A Warrant exercisable for a period of 24 months to purchase ½ share of Common Stock at the equivalent of $0.50 per share; and (iii) one Callable Class B Warrant exercisable for a period of 36 months to purchase ½ share of Common Stock at the equivalent of $1.25 per share. The Reg S Unit Offering was made in an “offshore transaction” to 18 accredited, all of whom were non “U.S. Persons” as defined in Rule 902(h) promulgated by the SEC under the Act.



In addition, after the quarter ended June 30, 2018, the Company’s executive officers and chairman converted debt in the aggregate amount of $275,303 into units consisting of a total of: (i) 2,753,030 restricted shares, 1,376,515 Class A Warrants and Class B Warrants, having the same terms as the Class A and Class B Warrants set forth in the Reg S Unit Offering, and 2,750,000 Class C Warrants exercisable to purchase one share of Common Stock at a price of $1.00 per Share.



The Company intends to use the total equity capital raised under its Registration Statement and Reg S Unit Offering for general corporate purposes, including working capital and capital expenditures in furtherance of development and commercialization of its BST Device, a new and novel electrotherapy for the non-invasive treatment of hard-to-heal chronic wounds. The BST Device has received the Conformité Européenne (European Conformity -“CE”) mark and was approved to be sold in the EU market.



https://www.sec.gov/Archives/edgar/data/1563536/000149315218014603/form8-k.htm

Volume is still crappy here...
But it is building as of late.

0.08s are gone now... time for some great news soon...

#lotto

EQUR news out Electrical Stimulation Therapy and E-Qure - A Potential 20x in 18 Months or Less

https://www.accesswire.com/464162/Electrical-Stimulation-Therapy-and-E-Qure---A-Potential-20x-in-18-Months-or-Less%20.

The product is approved in Israel and the EU. It is shortly awaiting reimbursement in both areas. Comically, the device and procedure are reimbursed but not approved in the U.S.

The company is negotiating with distributors and expects to finalize a deal by the end of the third quarter for the U.S. market. The Israeli and EU launches, meanwhile, may have a significant impact on the share price.

The company is preparing to initiate their U.S.-based clinical study. The study will include 90 patients randomized to either BST or a sham device, meaning that this is not a long or complicated trial to run. The study will be complete within 12 to 15 months, but interest will build in front of this important catalyst.

OMG, somebody buying everything up to 23 cents and half an hour later somebody hitting 13's on the downside? Are you friggin kidding me? How stupid can one be?

Being patient with this one...
But we will need something to happen

EQUR looks like some flippers from last dip trying to take some tiny profit here. LOL idiots

I couldn't find anything new from my side. Good for bulls.

Hmmm... that's a good chunk of money... wonder if there's something behind it...

DAMN

EQUR 0.23. someone took everything under 0.22 at one shot

OS is still 22,012,745 per OTC markets as of 3/29/17

m2m

Pretty quiet here lately...

Glen0 here with $EQUR

It is my opinion, that this very under the radar GEM has fallen RIGHT to the sweet spot for a potential MEGA run into dollars when DOTS start getting connected with the players involved here and the Israeli and FDA approvals.

Thie will not take long to catch on. It's very thin and that appeared to be released for potential liquidity as a dilutor was never pressing the box. By end of Friday it seemed all but done for now. Looks like we could move sharply if that's the case.

I will continue to monitor and release DD when we have more traction -

Love it ASK .33 now & thin

EQUR starting to roll out lots of good news

E-QURE's BST Device for Chronic Wound Care Receives Marketing Approval in Israel PR Newswire   "Press Releases US - English"

NEW YORK , February 24, 2017 /PRNewswire/ --

From Rig's board, RIGATONI  
Friday, 02/24/17 09:09:05 AM
Post # of 305348 
~EQUR .28 with 2 pieces of news...

https://www.otcmarkets.com/stock/EQUR/news/U-S--FDA-Approves-Increase-in-Number-of-Clinical-Sites-for-E-QURE-rsquo-s-Pivotal-Trial-of-BST-Device-for-the-Treatment-of-Chronic-Wound-Care?id=151856&b=y
E-QURE's BST Device for Chronic Wound Care Receives Marketing Approval in Israel

https://www.otcmarkets.com/stock/EQUR/news/E-QURE-s-BST-Device-for-Chronic-Wound-Care-Receives-Marketing-Approval-in-Israel?id=151947&b=y
U.S. FDA Approves Increase in Number of Clinical Sites for E-QURE’s Pivotal Trial of BST Device for the Treatment of Chronic Wound Care

Me too. Picked a few shares.

$EQUR Twitter is active #WoundCare: Huge Clinical and Economical Burden with yesterday's treatments. $EQUR 's BST is the future of wound care. pic.twitter.com/YnWOJbb4Hq— E-QURE (@EQUR_IR) February 22, 2017

EQUR took a few more today...shld see a pr soon.

Thanks hdogtx, got it.

You didnt scroll down to the SEC filings part

Hi Hdogtx, the link you provided for the 8k takes me to an old filing from 2016. thanks

http://www.otcmarkets.com/stock/EQUR/news

http://www.otcmarkets.com/stock/EQUR/filings

Take a peek, per news and filings we have insiders buying in open market, FDA approval, Distribution agreements internationally... and 2nd Q 2017 uplist to NASDAQ....

Market Value $6,603,769
a/o Feb 21, 2017

Authorized Shares 500,000,000
a/o Sep 30, 2016

Outstanding Shares 22,012,562
a/o Nov 21, 2016

Float 4,700,354
a/o May 31, 2016

EQUR 8k

next Israeli OWCP/TECR type

On February 20, 2017 , E-Qure Corp. (the "Registrant") received the official certification from the Israeli Ministry of Health authorizing the use of the Registrant's BST Device in Israel . The BST Device implements patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure.

http://archive.fast-edgar.com/20170222/AOK2D22CZ22TD2Z2222Q22ZLOAKNGZ224292

Is she going higher tomorrow?

Such a beast!!!!

EQUR 0.26 X 0.326

$EQUR here we go!!!!

You can try and contact the company . I can get you their info contact

Do you have an idea what peak sales would be?